Deprescribing Proton Pump Inhibitors in an Academic, Primary Care Clinic Quality Improvement Project

被引:14
|
作者
Nallapeta, Naren [1 ]
Reynolds, Jessica L. [2 ]
Bakhai, Smita [3 ]
机构
[1] Univ Buffalo State Univ New York, Dept Internal Med, Buffalo, NY 14215 USA
[2] Univ Buffalo State Univ New York, Dept Med, Buffalo, NY 14215 USA
[3] Univ Buffalo State Univ New York, ECMC, Dept Internal Med, Suite 15,462 Grider St, Buffalo, NY 14215 USA
基金
美国国家卫生研究院;
关键词
proton pump inhibitors; quality improvement; evidence-based guidelines; deprescribing PPI; primary care; inappropriate use of PPI; COMMUNITY-ACQUIRED PNEUMONIA; LONG-TERM USE; RISK; THERAPY; INFECTION; BENEFITS; OVERUSE; NEED;
D O I
10.1097/MCG.0000000000001317
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Goal: The goal of this study was to reduce the percentage of inappropriately prescribed proton pump inhibitors (PPIs) in patients aged 50 and older from 80% (baseline) to 60% within 12 months in an academic, internal medicine clinic. Background: The use of PPIs has increased drastically worldwide. Internal medicine clinic patients had inappropriate use of PPIs for an average of 4 to 5 years. Study: A multidisciplinary quality improvement team used the Plan-Do-Study-Act Model of health care improvement and performed a root cause analysis to identify barriers to inappropriate use of PPIs. The outcome measure was the percentage of patients inappropriately prescribed PPI. Process measures were completion rates of PPI risk assessment and esophagogastroduodenoscopy. Interventions included the creation of customized electronic health record templates and education to providers and patients. Analysis was performed using monthly statistical process control charts. Results: The average rate of PPI discontinuation was 51.1% (n=92/180), which corresponds to 30.0% inappropriate PPI usage within 12 months. The mean PPI discontinuation rate in the 1-year prestudy, study and 6 months poststudy period was 2.0%, 32.0%, and 49.7%, respectively. The mean esophagogastroduodenoscopy completion rate was 49.8% from the baseline of Conclusions: We achieved a statistically significant and sustainable reduction of inappropriate PPI use to 30% from the baseline rates of 80% and surpassed our goal within 12 months. This quality improvement was unique as no pharmacy personnel was utilized in this process. The multifaceted strategies in a safety-net internal medicine clinic resulted in successful deprescribing of PPI and can be replicated in other setting.
引用
收藏
页码:864 / 870
页数:7
相关论文
共 50 条
  • [1] Deprescribing Proton Pump Inhibitors: Quality Improvement Project
    Fernandez, Wilfor J. Diaz
    Forget, Nickole
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S623 - S624
  • [2] Successful deprescribing of unnecessary proton pump inhibitors in a primary care clinic
    Odenthal, Danielle R.
    Philbrick, Ann M.
    Harris, Ila M.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2020, 60 (01) : 100 - 104
  • [3] Improving Proton Pump Inhibitor Prescribing Practices in an Academic Safety Net Primary Care Clinic: Quality Improvement Project
    Nallapeta, Naren S.
    Bakhai, Smita Y.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S247 - S247
  • [4] Deprescribing proton pump inhibitors
    Turner, Justin P.
    Thompson, Wade
    Reeve, Emily
    Bell, J. Simon
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2022, 51 (11) : 845 - 848
  • [5] Deprescribing Proton Pump Inhibitors
    Zed, Peter J.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2018, 71 (05): : 291 - 292
  • [6] Deprescribing proton pump inhibitors
    Teh, Kim Jun Kevin
    Puar, Hai Kiat Troy
    How, Choon How
    Tan, Teck Kiang Malcolm
    SINGAPORE MEDICAL JOURNAL, 2023, 64 (08) : 503 - 507
  • [7] Deprescribing Proton Pump Inhibitors
    Kurlander, Jacob E.
    Gonzalez, Juan J.
    Saini, Sameer D.
    JAMA INTERNAL MEDICINE, 2020, 180 (12) : 1711 - 1712
  • [8] Improving the Reconciliation and Management of Proton Pump Inhibitors: A Quality Improvement Project
    Gonzalez, Adalberto
    Castillo, Michael
    Koop, Hans
    Cortizo, Jacqueline
    Chin, Jodi
    Beiro, Zaimat
    Hagar, Kristen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S238 - S238
  • [9] TEAMWORK PREVAILS - CONSTRUCTING A DEPRESCRIBING PROCESS FOR PROTON PUMP INHIBITORS WITH AN INTER-PROFESSIONAL TEAM AT AN ACADEMIC CLINIC
    Popplewell, Claire
    Block, Lauren
    Hirschwerk, David
    LaVine, Nancy A.
    Lu, Celia
    Mazzola, Nissa
    Chim, Christine
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S830 - S830
  • [10] Deprescribing strategies for proton pump inhibitors
    Young, Julia
    Fuller, Jordan A.
    Guidry, Corey M.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2024, 37 (11): : 51 - 51